OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 30.75% | 17.81% | 30.35% | 33.84% | 7.44% |
| Total Depreciation and Amortization | -96.46% | 97.55% | 9.98% | 11.01% | 11.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -163.51% | 107.16% | -79.52% | 1,398.52% | 201.95% |
| Change in Net Operating Assets | 161.44% | 171.55% | -30.64% | 106.97% | -79.54% |
| Cash from Operations | 33.98% | 37.92% | 17.73% | 58.27% | 7.72% |
| Capital Expenditure | 93.47% | -- | 100.00% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.30% | -- | 100.00% | 100.00% | 2.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 24.20% | 24.63% | -77.50% | -122.79% | -123.04% |
| Issuance of Common Stock | 1,615.74% | -- | -99.41% | -100.00% | -99.55% |
| Repurchase of Common Stock | 89.80% | 90.75% | 97.79% | 61.48% | 62.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,630.84% | -331.88% | -112.57% | 104.22% | -100.47% |
| Cash from Financing | 2,580.21% | 6.61% | -2,366.98% | -105.05% | -100.38% |
| Foreign Exchange rate Adjustments | 312.71% | -1,063.95% | -7,000.00% | -780.43% | -570.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.47% | 35.87% | 14.97% | 3.11% | -128.82% |